Expanded Human Stem Cells

Since their initial description, it has been documented that mesenchymal stem cells (MSCs) do not express proteins that would cause our body to reject tissues or cells from other individuals. This enables allogeneic production of MSCs (using tissues from other people), allowing for a comprehensive battery of tests to document cell safety. These tests include assessments for sterility, endotoxins, and Mycoplasma, following international standards. Additionally, this methodology allows us to implement a wide range of tests to document cell identity and viability, which also helps establish their therapeutic potency. We have developed a complete, secure, and controlled working protocol, including proprietary solutions that enable us to produce our cells while adhering to the strictest quality standards. As a result, we have positioned ourselves as one of the most reputable producers of this type of cell. The use of our cells does not require complex logistical or infrastructural conditions for healthcare delivery, positively impacting the quality of life for individuals located in different countries affected by diverse conditions such as osteoarthritis, autoimmune diseases, pulmonary issues, or the natural aging process.

Autologous Mononuclear Cells

Through a rapid and safe process, a heterogeneous population of cells can be obtained. These cells have been described as an accessible and convenient therapeutic tool for managing a wide range of inflammatory or degenerative conditions and injuries, particularly in young individuals. Since it is an autologous product, obtaining a bone marrow sample from the patient is necessary. This sample is then sent to our facilities, where we prepare it for use in various therapeutic procedures

Exosomes Produced By Human Mesenchymal Stem Cells

Secretory vesicles play a crucial role in intercellular communication, allowing our cells to exchange messages. These vesicles are loaded with a diverse array of molecules, each possessing distinct biological capabilities. These capabilities include simple biological processes related to tissue repair (such as cell proliferation and migration) as well as more complex functions like immunomodulation and inflammation control. The biological properties of the molecules within exosomes make them valuable therapeutic tools. They can be used to manage a wide range of conditions, injuries, and degenerative diseases, including diverse conditions like osteoarthritis, sports injuries, alopecia, skin disorders, erectile dysfunction, dyslipidemia, and other metabolic conditions1

Platelet-derived growth factors

A safe, cost-effective, and easily implementable therapeutic option for treating a diverse and heterogeneous set of pathologies and conditions, including those related to the musculoskeletal system. The growth factors we offer overcome the inherent limitations of platelet-rich plasma (PRP) therapy.

Need More Information?

Visit our Medical Information page to learn more about our products.